Review
Aug 2026
Rational drug design for Alzheimer's disease: from approved therapies to next-generation clinical candidates and AI-guided innovation.
The incorporation of artificial intelligence (AI) and machine learning (ML) is expected to enhance the prediction of pharmacokinetic, pharmacodynamic, and toxicity parameters in AD drug design.
Sana Saffour, Turgut Seçkin Gül, H. Gul
· Future Medicinal Chemistry · 0 citations